Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?
Pauline Kordalski1, Florence Huguet2
1Service d'oncologie radiothérapie, centre hospitalier universitaire Grenoble Alpes, La Tronche, France.
Abstract:
The role of radiation therapy in the treatment of pancreatic cancer has been debated for many years. Recent advances in radiation techniques with the development of stereotactic body radiotherapy and magnetic resonance imaging-guided radiotherapy have opened new therapeutic possibilities, enabling the delivery of ablative doses while minimizing the dose received by surrounding organs at risk. In this context, the potential benefit of radiation therapy should be questioned again.

